Status:

COMPLETED

Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC

Lead Sponsor:

Jennifer Keiser

Collaborating Sponsors:

Public Health Laboratory Ivo de Carneri

Conditions:

Trichuriasis

Ascariasis

Eligibility:

All Genders

2-5 years

Phase:

PHASE2

Brief Summary

This study is a single-blind randomized controlled dose-ranging trial aiming at providing evidence on the on the optimal dose of co-administered ivermectin and albendazole in terms of efficacy, safety...

Detailed Description

This study is a single-blind randomized controlled dose-ranging trial aiming at providing evidence on the optimal dose of co-administered ivermectin and albendazole in terms of efficacy, safety and ac...

Eligibility Criteria

Inclusion

  • individuals aged 2-5 years (24-71 months; confirmed by birth certificate or similar document)
  • having given written informed consent signed by parents/caregivers
  • being able and willing to provide two stool samples at baseline and at follow-up assessment (14-21 days)
  • having at least two out of four Kato-Katz slides positive for T. trichiura at baseline
  • being able and willing to be examined by a study physician before and after treatment

Exclusion

  • presence or signs of major systemic illness, e.g. fever (temporal body temperature of \>38.0°C), severe anaemia (haemoglobin level of \<70 g/l)
  • history of severe acute disease or unmanaged, severe chronic disease (i.e., condition is not as therapeutically controlled as necessary)
  • use of anthelminthic drugs during study period
  • known allergy to study medication (i.e., ivermectin or albendazole)
  • being prescribed or taking concomitantly medication with known contraindications or drug interactions with the study medication
  • concurrent participation in other clinical trials

Key Trial Info

Start Date :

June 5 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 9 2024

Estimated Enrollment :

260 Patients enrolled

Trial Details

Trial ID

NCT06184399

Start Date

June 5 2024

End Date

August 9 2024

Last Update

September 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Public Health Laboratory Ivo de Carneri

Chake Chake, Tanzania

Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC | DecenTrialz